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Abstract 
 
Psychomotor stimulant abuse is a significant public health problem.  While many 
individuals experiment with stimulants, there is marked variability in individuals’ 
behavioral and subjective response to these drugs and these differences may be associated 
with their risk for abuse.  One characteristic shown to be associated with drug abuse is 
sensation seeking, defined as the seeking of novel sensations and experiences and the 
willingness to take risks for the sake of such experiences.  While observational studies 
have shown that individuals with elevated sensation seeking are more likely to report 
stimulant use and abuse, less clear is whether subjective and behavioral response to acute 
stimulant administration may vary as a function of sensation seeking status.  We recently 
completed an outpatient laboratory study in which 37 healthy adults received repeated 
opportunities to sample and choose between d-amphetamine (d-AMPH; 5, 10, 20 
mg/70kg) or placebo.  That study provided an opportunity to examine associations 
between sensation seeking and d-AMPH choice and subjective response under rigorous 
double-blind experimental conditions.  The Zuckerman Sensation Seeking Scale V was 
administered at intake, providing a Total sensation seeking score as well as four subscales 
(i.e., Experience Seeking, Disinhibition, Thrill and Adventure Seeking, Boredom 
Susceptibility).  We hypothesized that elevated sensation seeking at intake would be 
associated with increased preference for d-AMPH over placebo in subsequent choice 
sessions, as well as greater positive d-AMPH subjective effects.  Among males, increased 
baseline sensation seeking was associated with increased d-AMPH choice and positive 
subjective effects at the 5 and 10 mg/70 kg doses.  Among females we found no 
significant associations between sensation seeking and d-AMPH choice or subjective 
effects.  Finally, when the association between sensation seeking and other baseline 
characteristics was examined, there was a significant positive association with lifetime 
drug use as well as impulsivity.  Taken together, our data suggest that elevated sensation 
seeking in males may be associated with increased sensitivity to d-AMPH reinforcement 
and positive subjective effects, suggesting increased vulnerability for stimulant use and 
abuse.   
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Introduction 
Abuse of psychomotor stimulants is a serious public health problem in the United 
States.  In addition to the 1.6 million current cocaine users, rates of methamphetamine 
abuse have increased in recent years, with 133,000 new methamphetamine initiates in 
2012 alone (SAMHSA, 2013a).  Abuse is also increasing for the stimulant medications 
widely used to treat attention deficit hyperactivity disorder (ADHD), including 
methylphenidate (Ritalin®), dextro-amphetamine (Dexedrine®) and mixed-salts 
amphetamine (Adderall®) (Kaye & Darke, 2012).  Between 2005-2010, for example, the 
number of annual emergency department visits involving these medications more than 
doubled from 13,379 to 31,244 (SAMHSA, 2013b).  The increase in stimulant abuse has 
been especially marked among adolescents and young adults, with a near four-fold 
increase in stimulant-related emergency department visits among those ages 18-25 
(SAMHSA, 2013b).  Abuse of psychomotor stimulants in general is associated with a 
variety of deleterious health consequences, including autonomic nervous system 
dysfunction, cardiovascular pathology, cognitive impairment, neurologic and psychiatric 
problems, poor psychosocial functioning and increased involvement in high-risk sexual, 
criminal and violent behavior (Cavazos-Rehg et al., 2009; Henry, Minassian, & Perry, 
2012; SAMHSA, 2005, 2008; Winslow et al., 2007).  
While the abuse potential of stimulants is well established (e.g., Chait, Uhlenhuth, 
& Johanson, 1987; Johanson & Fischman, 1989; Johanson & Uhlenhuth, 1980; Kollins, 
MacDonald & Rush, 2001), many individuals experiment with these drugs without 
transitioning to abuse or dependence.  Of those who report lifetime cocaine use, for 
example, only about 15% will go on to develop dependence (Wagner & Anthony, 2002).  
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Individuals also vary greatly in both subjective and behavioral response to stimulants and 
these differences may translate to differences in susceptibility to abuse (de Wit, 1998; de 
Wit & Phillips, 2012; de Wit, Uhlenhuth,  & Johanson, 1986; Silberman, Reus, Jimerson, 
Lynott, & Post, 1981).  In studies examining preference for amphetamine over placebo, 
for example, those who consistently choose amphetamine typically report increased 
ratings of positive mood, while those who consistently choose placebo report either no 
effects or greater negative effects of amphetamine (de Wit, Uhlenhuth, & Johanson, 
1986; Gabbay, 2003; Johanson, Kilgore, & Uhlenhuth, 1983).  An improved 
understanding of these individual differences would inform efforts to identify and 
intervene with those at risk for developing abuse or dependence. 
Sensation Seeking 
 
One characteristic shown to be associated with drug use and other risk behaviors 
is sensation seeking.  Sensation seeking (SS) is regarded as a stable personality trait and 
defined as the “seeking of varied, novel, complex, and intense sensations and 
experiences, and the willingness to take physical, social, legal and financial risks for the 
sake of such experiences” (Zuckerman, 1994).  The construct of SS is based on the 
premise that individuals vary widely in their optimal level of arousal, and these 
differences influence behavior (Zuckerman, 2007).  High sensation seekers, for example, 
are those who are more likely to engage in behaviors that increase the amount of 
stimulation they experience and therefore are hypothesized to have a greater likelihood of 
engaging in high-risk behaviors (Zuckerman, 1994).  
Sensation Seeking and Risk Behaviors 
Research over the past two decades has demonstrated an association between SS 
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and a wide range of risk behaviors (see Arnett, 1992 for review).  These have included 
gambling (Cyders & Smith, 2008; Powell, Hardoon, Derevensky, & Gupta, 1999; Shead, 
Derevensky, & Gupta, 2010), risky driving (i.e., racing, unsafe passing, high speeds, 
DWI; see Jonah, 1997 for review), sports-related risks (i.e., failure to use protective gear; 
Horvath & Zuckerman, 1993; Ruedl, Abart, Ledochowski, Burtscher, & Kopp, 2012) and 
risky sexual behavior (i.e., increased number of sexual partners, insufficient condom use; 
Gonzalez et al., 2005; Wagner, 2001).  In a survey of sexual risk behaviors among 
adolescents, for example, those with elevated SS reported increased frequency of sexual 
intercourse, a greater number of sexual partners and less consistent condom use 
(Spitalnick et al., 2007).  
Elevated SS scores have also been linked to increased substance use.  This has 
included licit drugs such as tobacco (Gunning, Sussman, Rohrbach, Kniazev, & 
Masagutov, 2009; Hampson, Tildesley, Andrews, Barckley, & Peterson, 2013) and 
alcohol (Bekman, Cummins, & Brown, 2010; Puente, Gonzalez Gutierrez, Abellan, & 
Lopez, 2008; Sargent, Tanski, Stoolmiller, & Hanewinkel, 2010), as well as illicit drugs 
including marijuana (Kopstein, Crum, Celentano, & Martin, 2001; Martin et al., 2002), 
opioids (Franques et al., 2003; Kosten, Ball, & Rounsaville, 1994) and stimulants 
(described below).   
SS may also be associated with dependence severity, treatment retention and 
therapeutic response among individuals with established drug dependence (Ball, Carroll, 
& Rounsaville, 1994; Kahler, Spillane, Metrik, Leventhal, & Monti, 2009; Patkar et al., 
2004).  A study evaluating the influence of SS on smoking cessation among heavy social 
drinkers, for example, found that those with elevated SS at intake had reduced odds of 
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smoking abstinence, poorer treatment compliance (i.e., nicotine replacement therapy 
adherence, use of cessation strategies) as well as greater alcohol use during treatment 
(Kahler et al., 2009).  
Sensation Seeking and Psychomotor Stimulant Use  
The association between SS and psychomotor stimulant abuse has been of 
particular focus.  In national surveys of the general population, elevated SS scores have 
been associated with higher prevalence rates of cocaine (Saiz et al., 2003), ecstasy (Wu, 
Liu, & Fan, 2010) and methamphetamine use (Herman-Stahl, Krebs, Kroutil, & Heller, 
2007).  Elevated SS scores have also been associated with prescription stimulant misuse, 
particularly among adolescents (Herman-Stahl, Krebs, Kroutil, & Heller, 2006) and 
young adults (Arria, Caldeira, Vincent, O'Grady, & Wish, 2008; Herman-Stahl, Krebs, 
Kroutil, & Heller, 2007; Jardin, Looby, & Earleywine, 2011; Low and Gendaszek, 2002; 
Van Eck, Markle, & Flory, 2012; Weyandt et al., 2009).  In one study, for example, 
adolescents with elevated SS had almost a 2.5-fold increased odds of past year 
nonmedical stimulant use compared to lower-SS adolescents (Herman-Stahl, Krebs, 
Kroutil, & Heller, 2006).  Additionally, stimulant-dependent individuals have higher SS 
scores compared to non-drug dependent siblings and matched controls (Ersche, Jones, 
Williams, Smith, Bullmore, & Robbins, 2013; Ersche, Turton, Pradhan, Bullmore, & 
Robbins, 2010).  Finally, SS may also be associated with severity of stimulant use in 
clinical populations.  In an analysis of treatment-seeking cocaine users, for example, SS 
was positively correlated with frequency of cocaine use and having a cocaine-positive 
urine at treatment intake (Murray et al., 2003).  Taken together, these studies have 
suggested a general association between SS and stimulant use, though more controlled 
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investigations are needed to improve our understanding of this association.  
Laboratory Studies Examining Sensation Seeking and Stimulant Use  
Seven laboratory studies have examined the association between SS and 
participants’ sensitivity to the subjective and reinforcing effects of psychomotor 
stimulants (Carrol, Zuckerman, & Vogel, 1982; Chait, 1993; de Wit, Uhlenhuth, & 
Johanson, 1986; Hutchison, Wood, & Swift, 1999; Kelly et al., 2006, 2009; Stoops et al., 
2007).  All used d-amphetamine (d-AMPH) as the exemplar stimulant, as it is a classic 
psychomotor stimulant that produces effects similar to those of cocaine, 
methamphetamine and other commonly-abused stimulants (O’Brien, 2001).  Sensation 
Seeking in those studies was measured using either the Sensation Seeking Scale V (SSS; 
Zuckerman et al., 1978) or the Zuckerman-Kuhlman Personality Questionnaire (ZKPQ; 
Zuckerman, Kuhlman, Joireman, Teta, & Kraft, 1993).   
All seven studies examined the association between participants’ SS scores and 
their subjective response to d-AMPH (Carrol et al., 1982; Chait, 1993; de Wit et al., 
1986; Hutchison et al., 1999; Kelly et al., 2006, 2009; Stoops et al., 2007).  Subjective 
effects were measured using the Addiction Research Center Inventory (ARCI; Haertzen, 
Hill, & Belleville, 1963), Drug Effects Questionnaire (DEQ; Fischman & Foltin, 1991), 
Profile of Mood States (POMS; McNair, Lorr, & Droppleman, 1971) or Visual Analog 
Scales (VAS; Folstein & Luria, 1973).  In four studies, participants with higher SS scores 
showed increased sensitivity to d-AMPH effects compared to those with lower scores 
(Hutchison et al., 1999; Kelly et al., 2006, 2009; Stoops et al., 2007), while three found 
no influence of SS on d-AMPH subjective effects (Carrol et al., 1982; Chait, 1993; de 
Wit et al., 1986).  Among those demonstrating increased d-AMPH sensitivity among 
  6 
participants with higher SS scores, the nature of the effect observed varied.  In three 
studies, for example, participants with higher SS showed increased sensitivity to d-
AMPH’s positive effects (e.g., stimulation, elation, drug liking) (Hutchison et al., 1999; 
Kelly et al., 2006, 2009), while in the fourth study those with higher SS scores showed 
increased sensitivity to d-AMPH’s negative effects (e.g., anger, confusion) (Stoops et al., 
2007).   
Three of the seven studies also examined the role of SS in d-AMPH 
reinforcement (Chait, 1993; de Wit et al., 1986; Stoops et al., 2007).  Two employed a 
discrete-trial choice procedure to investigate the role of SS in d-AMPH reinforcement 
(7.5-20 mg, Chait, 1993; 5 mg, de Wit et al., 1986).  In choice procedures, participants 
are given an opportunity to sample and choose between two concurrently-available 
alternatives.  This arrangement provides an index of the relative preference for one of two 
alternatives, with the frequency with which one option is chosen over the other providing 
an index of the relative reinforcing effects of the drug (de Villiers, 1977; Mazur, 1994).  
Participants in both studies were dichotomized into Choosers and Nonchoosers based on 
the percentage of sessions wherein they chose active d-AMPH over placebo, and there 
were no significant differences in Total SS scores between Choosers and Nonchoosers in 
either study.  However, while not statistically significant, mean SS scores were in the 
expected direction with Choosers having higher SS scores than Nonchoosers (de Wit et 
al., 1986; means not reported in Chait, 1993).  
The third study evaluating SS and d-AMPH reinforcement used a progressive 
ratio (PR) procedure (Stoops et al., 2007).  In PR procedures, participants are provided 
the opportunity to work (e.g., pull a lever, press a computer key) to receive a reinforcer.  
  7 
The response requirement for obtaining each drug reinforcer increases following delivery 
of the previous reinforcer (Hodos, 1961).  Response requirements continue to escalate 
until responding terminates, and the final ratio completed (i.e., break point) provides an 
index of the magnitude of the reinforcing effects of the drug.  In the Stoops et al. (2007) 
study, participants with higher SS scores demonstrated greater break points for both 8 and 
16 mg d-AMPH doses compared to those with lower SS scores, suggesting that elevated 
SS was associated with increased sensitivity to d-AMPH reinforcement.   
While these studies have generally suggested that baseline SS may influence 
individuals’ sensitivity to d-AMPH’s subjective and reinforcing effects, there was 
variability across studies.  Several methodological details may have contributed to this.  
First, failure to examine a sufficient range of doses could have limited the ability to detect 
an effect in some studies.  Of the three studies that failed to find a significant association 
between SS and d-AMPH, for example, each examined only a single d-AMPH dose 
(Carrol et al., 1982; Chait, 1993; de Wit et al., 1986).  Of the four that demonstrated a 
significant association between SS and d-AMPH, three examined multiple doses (Kelly et 
al., 2006, 2009; Stoops et al., 2007).  Considering that individual differences in subjective 
and behavioral responses to drugs may be dose dependent, assessing multiple doses may 
be important for obtaining a thorough characterization of the association between SS and 
stimulant response (White, Lott, & de Wit, 2006).   
Second, the prior studies may have been constrained by the failure to consider 
potential gender differences.  Gender differences in SS have been consistently reported, 
and the developer of the Sensation Seeking Scale V, the most widely-used instrument for 
measuring SS, has published gender-specific norms for use in data interpretation 
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(Zuckerman et al., 1978; Zuckerman, 1994).  Indeed, in a recent meta-analysis of SS 
across multiple cultures, men generally had significantly higher scores on the Total, 
Thrill and Adventure Seeking, Disinhibition and Boredom Susceptibility scales of the 
SSS compared to women (Cross, Cyrenne, & Brown, 2013).  Of the three laboratory 
studies above that failed to find a significant association between SS and d-AMPH, two 
did not consider gender differences in SS (Chait, 1993; de Wit et al., 1986).  Of the four 
that demonstrated a significant association between SS and d-AMPH, three either used 
gender as a covariate or selected participant groups based on gender-specific SS cutpoints 
(Kelly et al., 2006, 2009; Stoops et al., 2007). 
Finally, limited use of the Sensation-Seeking Scale’s subscales may have 
precluded a full characterization of the SS-stimulant association in prior studies.  The 
questionnaire includes a Total composite SS score as well as four subscales, with each 
subscale contributing unique variance (Zuckerman, 1994).  Of the five studies above that 
used the Sensation Seeking Scale V (Carrol et al., 1982; Chait, 1993; de Wit et al., 1986; 
Hutchison et al., 1999; Kelly et al., 2009), only one examined the four subscales.  It 
found a significant association between participants’ d-AMPH response and their scores 
on the Experience Seeking, Disinhibition and Boredom Susceptibility scales (Hutchison 
et al., 1999).  Of the four that solely relied on the Total scale as a measure of SS, only one 
showed a significant association between SS and d-AMPH response (Kelly et al., 2009).   
Current Study 
 
In the present study, we conducted a secondary analysis of data obtained in an 
outpatient laboratory study conducted at the University of Vermont from November 2009 
to March 2012.  As a growing scientific literature suggests that vulnerability for drug 
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abuse is influenced by genetic factors (Comings & Blum, 2000; Uhl, 2006), the parent 
study sought to examine the influence of a specific dopaminergic polymorphism, the 
dopamine D2 receptor (DRD2) A1 allele, on individual differences in sensitivity to d-
AMPH reinforcement (Sigmon et al., in preparation).  Healthy adult volunteers were 
prospectively identified as DRD2 A1 carriers or noncarriers and then completed double-
blind laboratory sessions wherein they received repeated opportunities to sample and 
choose between d-AMPH (5, 10 and 20 mg/70 kg) and placebo.  Participants completed a 
Drug Effects Questionnaire prior to capsule ingestion and again at 1, 2, 4 and 8 hours 
post-drug administration.  Percent of d-AMPH choices and self-report DEQ ratings 
served as measures of d-AMPH reinforcing and subjective effects, respectively.  
Analyses of the primary outcomes are ongoing and the resulting manuscript will be 
submitted to a peer-reviewed scientific journal in upcoming months (Sigmon et al., in 
preparation).   
While the primary aim of the parent study was to investigate the influence of the 
DRD2 A1 allele on sensitivity to d-AMPH reinforcement, the study provided a unique 
opportunity to examine the association between participants’ SS and their subsequent 
sensitivity to d-AMPH’s subjective and reinforcing effects.  All participants completed 
the Sensation Seeking Scale V (Zuckerman et al., 1978) at study intake.  We 
hypothesized that elevated SS would be associated with increased d-AMPH choice as 
well as positive subjective effects.  As a secondary exploratory aim, we also examined 
the association between SS and baseline demographic and drug use characteristics in our 
sample.  Overall, this study is the first to our knowledge to investigate the influence of 
sensation seeking on d-AMPH reinforcement and subjective response within gender 
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using the SSS-V total scale and each of its subscales.  As such, it is positioned to provide 
a thorough investigation of whether SS influences d-AMPH response under controlled 
conditions, providing data relevant to the issue of whether sensation seeking may 
influence individuals’ vulnerability for stimulant abuse.   
Method 
Participants 
Participants were 37 healthy adult volunteers between the ages of 18-50, recruited 
through electronic and community postings.  To be eligible for that study, participants 
were required to report a history of limited recreational stimulant (e.g., methylphenidate, 
cocaine) use but not meet DSM-IV criteria for current or lifetime abuse or dependence 
and not be seeking treatment for alcohol or drug abuse or dependence.  All were required 
to submit a drug-negative sample to eliminate physically dependent or regular drug users, 
which is consistent with prior studies investigating vulnerabilities that may predispose 
individuals to the development of drug abuse (cf. de Wit, 1998).  Participants were 
required to be in good health, be fluent in English and capable of understanding and 
complying with the protocol.  Females had to be non-pregnant and non-lactating, and 
those of childbearing age were required use appropriate birth control for the study 
duration.  Exclusion criteria included known hypersensitivity or medical contraindication 
to psychomotor stimulants, history of or current significant medical or psychiatric 
condition (including a diagnosis of ADHD), diastolic blood pressure >90 mmHg or 
systolic pressure of >140 mmHg, body weight 20% above or below ideal body weight 
and use of prescription or over-the-counter medications that could interfere with the 
study.  The study was approved by the local institutional review board and each 
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participant provided written informed consent prior to participating. 
Intake Assessment 
Participants completed an intake assessment that included measures previously 
associated with drug abuse vulnerability and/or stimulant choice: Sensation-Seeking 
Scale Form V (SSS-V; Zuckerman et al., 1978; described below), Barratt Impulsiveness 
Scale – 11 (BIS-11; Patton, Stanford, & Barratt, 1995), Beck Anxiety Inventory (BAI; 
Beck et al, 1988), and Behavioral Inhibition Scale and Behavioral Activation Scale 
(BIS/BAS; Carver & White, 1994).  A drug history questionnaire, modified Time-Line 
Followback interview (Sobell, Sobell, Leo, & Cancill, 1988) and the DSM-IV 
psychoactive substance and alcoholism sections (Feingold & Rounsaville, 1995) were 
used to assess lifetime and recent drug use.  Participants also completed a medical 
history, which the principal investigator and physician reviewed to confirm eligibility.  
Finally, urine and breath alcohol samples were collected and tested for recent drug and 
alcohol use.   
Measures of Sensation Seeking and d-AMPH Response 
The SSS-V contained 40 forced-choice questions yielding four subscales of 10 
items each (Zuckerman et al., 1978), as well as a Total score.  The Experience Seeking 
subscale assessed the desire to experience novel sensations and experiences through 
social nonconformity.  The Disinhibition subscale assessed the desire to seek sensations 
through social activities such as parties, drinking and sex.  The Thrill and Adventure 
Seeking subscale measured the desire to engage in sports or risky physical activities.  The 
Boredom Susceptibility subscale assessed intolerance to monotony.  Total scores could 
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range from 0-40 and subscales ranged from 0-10; on both, increased scores represented 
increased levels of sensation seeking.   
The Drug Effects Questionnaire (DEQ) included five items that assess direct drug 
effects (i.e., Drug Effect, Stimulant Effect, Good Effects, Bad Effects, Liking) shown in 
previous research to be related to abuse potential (e.g., King, de Wit, McNamara, & Cao, 
2011; Morean et al., 2013).  All items, with the exception of Liking, were scored using a 
Likert scale that ranged from 0 (not at all) to 4 (extremely).  Subjects rated their Liking of 
the drug from -4 (dislike very much) to +4 (like very much), in order to permit a neutral 
or no drug liking rating.  
Procedures 
The double-blind, discrete-trial choice procedure consisted of 36 sessions (3-5 
sessions per week) conducted over approximately 7 weeks, depending on participants’ 
schedules.  Three d-AMPH doses were evaluated, with each dose involving 12 sessions.  
Each of these 12-session series involved 4 sequences of 3 sessions per sequence (Sample-
Sample-Choice; described below).  At each session, participants provided a urine and 
breath sample, completed a baseline DEQ and ingested 2 color-coded capsules.  After 
leaving the laboratory, participants completed the DEQ at 1, 2, 4, and 8 hours post-drug.   
Each 3-session sequence began with two “sample” days during which participants 
received different color-coded capsules each day (e.g., 2 red capsules on Monday and 2 
green capsules on Tuesday).  One pair always contained placebo and the other d-AMPH.  
On the subsequent “choice” day, participants reviewed their self-report data from the 
prior sample days to help recall specific drug effects associated with each pair of color-
coded capsules and then chose to ingest one of the two capsule pairs.  Participants were 
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informed that the content of each pair of color-coded capsules in the choice session was 
identical to that of the preceding two sample sessions.  This 3-day sequence (2 sample 
days followed by 1 choice day) was repeated for a total of 4 experimentally-independent 
assessments (12 total sessions) at each d-AMPH dose (i.e., 5, 10 and 20 mg/70kg).  In 
summary, 36 total sessions were conducted, with 12 (4 Sample-Sample-Choice 
sequences) sessions at each d-AMPH dose.  The order of exposure to d-AMPH and 
placebo was counterbalanced within and across trials and subjects, and order of exposure 
to the different d-AMPH doses was counterbalanced across subjects.   
Study Medication 
 d-AMPH capsules (5, 10 or 20 mg/70kg; size 0, opaque hard gelatin) were 
prepared by the University of Vermont investigational pharmacy using powdered lactose 
and d-amphetamine sulfate.  Placebo capsules were weight matched (+/- 5%) and 
prepared using powdered lactose.  Color of d-AMPH and placebo capsules varied across 
sessions, with 7 capsule colors and 28 possible color combinations (including solid-
colored capsules and capsules with each half a different color). 
Statistical Analyses 
T-tests were used to compare male and female participants on mean SS scores, as 
well as for comparison within gender to published norms.  Due to established gender-
specific differences in SS scores (Cross, Cyrenne, & Brown, 2013; Zuckerman, 1994), 
the association between SS and d-AMPH reinforcing and subjective effects were 
analyzed within gender.  With regard to d-AMPH choice, logistic regression analyses 
based on generalized estimating equations (GEE) were used to examine the association 
between each SS scale and d-AMPH choice (SAS, PROC GENMOD).  This 
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methodology accounts for the repeated measures structure in the choice data, as each 
participant had multiple opportunities to choose between d-AMPH and placebo at each of 
the three dose levels.  First, the association between SS and choice was evaluated across 
all three d-AMPH dose levels, with dose (5, 10, 20 mg) as additional predictors 
represented by indicator variables in the model.  This reflects a main effect model, as the 
effect of each SS subscale is assumed to be independent of dose.  Subsequently, simple 
effect models were examined in which SS was used to predict choice at the individual 
dose levels.  Predicted probabilities were computed based on the derived logistic 
regression equations.  In order to have derived odds ratios represent a meaningful change 
in SS score, a 5-point change was used for the Total SS scale (range: 0-40), and 2-point 
change was used for each of the subscales (range: 0-10).   
With regard to d-AMPH’s subjective effects, mixed model repeated measures 
ANCOVAs were used to examine the effects of each SS scale on the five DEQ drug 
effects items.  The dependent variable for each item was the area under the curve 
representing the cumulative drug effect over time (8 hours).  Consistent with prior 
studies, subjective effects analyses were limited to the data collected from the sample 
sessions in order to avoid the potential bias associated with choice sessions (Sigmon & 
Griffiths, 2011).  In order to isolate the effect of active d-AMPH dose on subjective 
response, all regression models included participants’ subjective effects during placebo 
administration as a covariate.  Similar to the logistic regression methodology reported 
above, separate models were performed for each SS scale as a predictor.  Main effect 
models were run across the three dose levels with dose as an additional explanatory 
variable, followed by simple effect models evaluating the dose-specific association.  
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Finally, the association between SS Total and a priori identified baseline demographic, 
drug use and psychosocial characteristics was examined using Pearson’s correlation 
coefficient.  Participants’ DRD2 A1 polymorphism status was not considered as a 
covariate in analyses as there was no evidence that choice or subjective effects varied as a 
function of allele status (Sigmon et al., in preparation).  Analyses were performed using 
SAS statistical software Version 9.3  (SAS Institute, Cary, NC).  Statistical significance 
was determined based on α = .05.   
Results 
Participant Characteristics 
 
The 37 participants were 22.9 + 2.9 years old, 43% male and had completed 15.1 
+ 1.3 years of education (Table 1).  In terms of drug use, 14% of participants were current 
cigarette smokers and 100% reported current alcohol use.  All reported lifetime marijuana 
use, and 22%, 32.4% and 67.6% reported lifetime benzodiazepine, opioid and 
hallucinogen use, respectively.  Consistent with study eligibility criteria, all participants 
reported prior recreational stimulant use, including cocaine (57%), amphetamines (e.g., 
Adderall®) (86%), methylphenidate (Ritalin®) (24%) and ecstasy (46%). See Table 1 for 
participant characteristics within gender.  There were no significant differences between 
males and females in demographic or psychosocial characteristics.  However, in terms of 
drug use, a significantly greater percentage of males had used stimulants > 10 times.  
Participants’ mean SS scores at study intake are presented in Table 2.  Contrary to 
normative data, there were no significant differences in SS between males and females.  
However, compared to norms, the mean Total score of our male participants was 
estimated to be at the 60th percentile, with significantly higher mean scores on the 
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Experience Seeking subscale compared to published male norms (p < .001) (Zuckerman, 
Kuhlman, Thornquist, & Kiers, 1991).  Similarly, our females’ mean Total score was 
estimated to be at the 80th percentile of normative data, with significantly higher mean 
scores on the Total, Experience Seeking and Thrill and Adventure Seeking scales 
compared to female norms (p’s < .01).  
Sensation Seeking and d-AMPH Choice 
Males chose 5, 10 and 20 mg/70kg d-AMPH over placebo on 56%, 52% and 61% 
of occasions, respectively (Wald X 2(2, N = 16) = 1.55, p = .46).  Among males, there was 
a significant positive association between Total, Experience Seeking, Disinhibition and 
Thrill and Adventure Seeking scale scores and d-AMPH choice (p’s < .05; Table 3).  
More specifically, each 5-point increase in Total SS score was associated with a 1.57 
odds of choosing d-AMPH, while each 2-point increase in Experience Seeking, 
Disinhibition and Thrill and Adventure Seeking scores was associated with a 1.87, 1.52, 
and 1.91 odds of choosing d-AMPH, respectively.  There was no significant association 
between Boredom Susceptibility and d-AMPH choice.  When these effects were 
examined within dose, the association between SS scores and d-AMPH choice was 
strongest at the 10 mg dose.  More specifically, each 5-point increase in Total SS score 
was associated with an odds ratio of 2.20 for choosing d-AMPH (Figure 1, top left panel), 
while each 2-point increase in Experience Seeking (Figure 1, bottom left panel), 
Disinhibition (Figure 1, top right panel) and Thrill and Adventure Seeking (Figure 1, 
bottom right panel) subscales was associated with odds ratios of 2.39, 1.81 and 2.85 for 
d-AMPH choice, respectively.  
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Females chose 5, 10 and 20 mg/70kg d-AMPH over placebo on 62%, 67% and 
70% of occasions, respectively (Wald X 2(2, N = 21) = 1.70, p = .43).  In contrast to 
males, analyses performed across and within dose showed no significant associations 
between any SS scale and d-AMPH choice among females (Table 3).  
Sensation Seeking and d-AMPH Subjective Effects 
 
Males showed a significant dose effect on all five DEQ items (F = 11.43-60.27, 
p’s <.05).  There was a significant positive association between male participants’ scores 
on the Total and Disinhibition scales and their ratings of d-AMPH Liking (p’s <.05), as 
well as a positive trend between Thrill and Adventure Seeking and d-AMPH Liking (p = 
.08) (Table 3).  More specifically, each 5-point increase in Total SS score was associated 
with a βof 1.17, while each 2-point increase in Disinhibition and Thrill and Adventure 
Seeking scores was associated with β’s of 1.00 and 1.39, respectively.  Within-dose 
analyses showed that the strongest associations between d-AMPH Liking and the Total  ( 
(β= 1.35, p = .07; Figure 2, top panel), Disinhibition (β=1.19, p = .04; Figure 2, bottom 
left panel) and Thrill and Adventure Seeking (β= 2.10, p =  .06; Figure 2, bottom right 
panel) scales occurred at the 5 mg dose.  In addition, there was a significant negative 
association between the Experience Seeking subscale and ratings of Bad Effects (β= -
1.87, p =  .01).  Within-dose analyses revealed that the negative association between 
Experience Seeking and Bad Effects was significant at the 10 mg (β= -2.25, p = .01) and 
20 mg (β= -2.91, p = .04) doses (Figure 3).  
Females showed a significant dose effect on all DEQ items except Bad Effects (F 
= 52.17-60.45, p’s  < .05).  There were no significant associations between any of the SS 
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scales and d-AMPH subjective effects in females (Table 3).  However, within-dose 
analyses showed a significant negative association between the Disinhibition subscale 
and Bad Effects at the 10 mg dose (β= -0.61, p = .04; Figure 4).  
Sensation Seeking and Baseline Characteristics 
 
Correlations between participants’ SS Total scores and baseline demographic, 
drug use and psychosocial characteristics were also examined (see Table 1 for variables).  
There were no significant associations between the Total scale and any demographic 
characteristics.  With respect to drug use, Total scores were significantly correlated with 
use of stimulants on greater than 10 occasions (r = .58, p = .01), as well as lifetime opioid 
(r = .55, p < .01) and hallucinogen use (r = .38, p = .02).  The Total scale was also 
significantly correlated with other measures of impulsivity, including BAS Fun Seeking 
(r = .50, p < .01), BIS-11 Motor Impulsiveness (r = .34, p = .04), BIS-11 Nonplanning 
Impulsiveness (r = .47, p < .01) and BIS-11 Total (r = .41, p = .01).  
Discussion 
 
Stimulant abuse represents a serious public health problem, with over 3.4 million 
Americans reporting past-month illicit stimulant use (SAMHSA, 2013a).  Efforts to 
identify the characteristics associated with susceptibility for stimulant abuse may help 
inform the development of more effective prevention and treatment efforts.  In the 
present study, we sought to examine whether sensation seeking, a characteristic 
commonly associated with drug use and other risk behaviors, was associated with 
increased sensitivity to d-AMPH reinforcement under double-blind experimental 
conditions.  
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Among males, there was a significant association between SS and d-AMPH 
choice.  Healthy volunteers with increased scores on the Total, Disinhibition, Thrill and 
Adventure Seeking, and Experience Seeking subscales had significantly greater odds of 
choosing d-AMPH over placebo, particularly at the 10 mg/70kg dose.  These results are 
consistent with those of Stoops and colleagues (2007) in which high-SS participants 
demonstrated increased break points for both 8 and 16 mg d-AMPH compared to low-SS 
participants.  Our findings differ from the two prior discrete-trial choice studies that 
found no such association between SS and d-AMPH choice (Chait, 1993; de Wit et al., 
1986), perhaps due to a lack of controlling for gender differences in those studies.  
Sensation Seeking was also significantly associated with d-AMPH subjective 
effects in males.  With regard to positive d-AMPH subjective effects, males with higher 
scores on the Total, Disinhibition and Thrill and Adventure Seeking scales reported 
greater d-AMPH Liking, particularly at the 5 mg/70kg dose.  These results are consistent 
with previous studies showing increased sensitivity to d-AMPH-associated positive 
effects among participants with higher SS scores (Hutchison et al., 1999; Kelly et al., 
2006, 2009), as well as the larger literature showing concordance between d-AMPH-
related positive effects and increased choice (Rush, Essman, Simpson, & Baker, 2001; 
Tancer, & Johanson, 2003).  In terms of negative d-AMPH effects, males with higher 
Experience Seeking scores reported lower ratings of Bad Effects, particularly at 10 and 
20 mg/70kg doses.  This is also consistent with a prior study in which higher sensation 
seekers showed reduced sensitivity to d-AMPH-associated unpleasant effects (e.g., anger, 
light-headed; Kelly et al., 2009).  Overall, these findings provide additional support for 
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increased vulnerability for stimulant abuse among males with elevated SS (Chait, 1994; 
de Wit, Uhlenhuth, & Johanson, 1986; Jaffe & Jaffe, 1989).   
In contrast to males, we found no significant association between SS and d-
AMPH choice or subjective response in female participants.  One possible reason may be 
related to the inclusion criteria used in the parent study, in which participants were 
required to have used stimulants in order to be eligible.  Thus, our sample of female 
participants may differ from the general female population in that they represent a more 
severe subset of the general population.  There is some evidence to suggest this, as our 
female participants had significantly higher scores on the Total, Experience Seeking, and 
Thrill and Adventure Seeking scales compared to the published norms for females 
(Zuckerman et al., 1991).    
Finally, we also examined correlations between SS and other baseline 
characteristics.  Sensation Seeking scores were significantly associated with lifetime use 
of stimulants, opioids and hallucinogens, supporting the larger literature showing an 
association between SS and drug use (Zuckerman, 2012).  In addition, SS scores were 
significantly correlated with other measures of impulsivity, including the BIS-11 and the 
BIS/BAS.  This supports prior assertions that impulsivity and sensation seeking 
characteristics are likely comprised of related factors (Meda et al., 2009; Magid, & 
MacLean, 2005; Stanford et al., 2009).  Indeed a factor analysis of several impulsivity 
and sensation seeking scales found that the Zuckerman SSS Total scale and each of the 
BIS-11 subscales loaded onto the same Self-Reported Impulsivity factor (Meda et al., 
2009).  
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Several strengths of the present study should be noted.  First, this study included a 
range of d-AMPH doses with multiple exposures at each dose level.  We found that the 
associations between SS and d-AMPH sensitivity were strongest at the 5 and 10 mg d-
AMPH doses, which supports previous findings suggesting that individual differences 
may be most pronounced at lower doses (White, Lott, & deWit, 2006).  Second, instead 
of ignoring gender or simply using it as a covariate, we directly examined the effects of 
SS on d-AMPH response within each gender and found a strong association between SS 
and d-AMPH in males that was not evident in females.  Third, while prior studies 
dichotomized participants into Low and High SS subgroups based on arbitrary cut-offs, 
which can result in suboptimal analyses, we examined SS as a continuous variable 
(Cohen, 1983).  Finally, this is the first study to our knowledge to use the SS Total score 
as well as each of the four subscales, thus providing the most thorough analysis to date of 
the association between SS and d-AMPH response.  Indeed, in males we saw significant 
associations between d-AMPH subjective effects and choice not only with the Total 
scale, but also the Disinhibition, Thrill and Adventure Seeking and Experience Seeking 
subscales.  
Several potential limitations should also be considered.  First, our sample size was 
restricted by the number of participants who completed the parent study.  That said, we 
observed several statistically significant and potentially important associations between 
SS and d-AMPH response despite the limited sample.  Also worth noting is that our 
sample size (n=37) was generally similar to those in prior studies on this topic (range = 
17-36).  Second, as we used a convenience sample of participants from a previously-
completed study, our participant selection was constrained by its eligibility criteria.  
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Those criteria may have skewed SS scores in our study sample and, as a result, may have 
limited our ability to observe an association between SS and d-AMPH in females.  
In summary, the present study sought to examine whether sensation seeking 
among healthy volunteers is associated with their sensitivity to d-AMPH’s subjective and 
reinforcing effects.  We found evidence that increased SS was associated with greater 
sensitivity to d-AMPH’s positive effects and greater d-AMPH preference in males.  
Taken together, SS may reflect an important characteristic underlying an individual’s 
sensitivity to stimulant reinforcement and risk for abuse. 
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Table 1
Baseline demographic, psychosocial and drug use characteristics
Total Sample Males Females p
(n=37) (n=16) (n=21)
Demographics
     Age 22.9 (2.9) 22.2 (2.2) 23.4 (3.3) 0.20
     Education (yrs) 15.1 (1.3) 15.1 (1.0) 15.2 (1.6) 0.78
Drug Use Characteristics
    Current smoker (%) 13.5 18.8 9.5 0.42
    Current alcohol use (%) 100 100 100 1.00
    Lifetime THC use (%) 100 100 100 1.00
    Lifetime benzodiazepines use (%) 21.6 12.5 28.6 0.24
    Lifetime opioid use (%) 32.4 43.8 23.8 0.21
    Lifetime hallucinogen use (%) 67.6 68.8 66.7 0.9
    Lifetime stimulant use (%) 100 100 100 1.00
        Cocaine (%) 56.8 50.0 61.9 0.47
        Adderall (%) 86.5 93.8 81.0 0.26
        Methylphenidate (%) 24.3 25.0 23.8 0.93
        Ecstasy (%) 45.9 62.5 33.3 0.08
        Stimulants > 10 times 24.3 43.8 9.5 0.03
Psychosocial Characteristics
    Beck Anxiety Inventory (0-63) 2.6 (2.9) 2.3 (3.0) 2.9 (2.9) 0.58
    Barratt Impulsivity Scale-11 (Total) (30-120) 57.6 (9.5) 58.6 (11.1) 56.8 (8.2) 0.57
       Attentional Impulsiveness (8-32) 14.5 (3.8) 14.3 (4.3) 14.6 (3.4) 0.85
       Motor Impulsiveness (11-44) 21.8 (3.3) 22.3 (3.9) 21.5 (2.8) 0.45
       Nonplanning Impulsiveness (11-44) 21.3 (4.6) 22.0 (5.1) 20.8 (4.2) 0.44
   Behavioral Inhibition/Behavioral Activation 
        BAS Drive (4-16) 11.6 (2.3) 11.1 (1.6) 12.0(2.6) 0.26
        BAS Fun Seeking (4-16) 12.7 (2.1) 13.3 (1.6) 12.4 (2.4) 0.22
        BAS Reward Responsiveness (5-20) 17.8 (2) 17.8 (1.5) 17.9 (2.3) 0.92
        BIS (7-28) 19 (3.3) 18.4 (3.1) 19.4 (3.5) 0.38
Note: Means (+s.d.) unless otherwise specified
p-values based on independent sample t-tests.
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Table 2
Sensation seeking characteristics
Total Sample Males Females p
(n=37) (n=16) (n=21)
    Total Sensation Seeking (0-40) 24.1 ± 5.1 24.5 ± 5.2 23.8 * ± 4.9 0.68
    Experience Seeking (0-10) 7.5 ± 1.4 7.2 * ± 1.6 7.7 * ± 1.3 0.28
    Disinhibition (0-10) 5.6 ± 2.0 5.9 ± 2.5 5.5 ± 2.3 0.54
    Thrill and Adventure Seeking (0-10) 7.9 ± 1.8 8.4 ± 1.5 7.6 * ± 2.0 0.19
    Boredom Susceptibility (0-10) 3.0 ± 1.9 3.0 ± 2.0 3.1 ± 2.0 0.92
Note: Means (+SD), significance levels based on t-tests
* indicates that value is statistically greater than published norms (p<.01) (Zuckerman, Kuhlman, Thornquist, & Kiers, 1991)
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Table 3
Effects of sensation seeking and d-AMPH choice 
Males (n=16) Females (n=21)
SS Scale Odds ratio 95% CI p Odds ratio 95% CI p
Total 1.57 (1.03, 2.38) 0.03 0.78 (0.49, 1.23) 0.28
   Experience Seeking 1.87 (1.05, 3.32) 0.03 0.64 (0.36, 1.13) 0.12
   Disinhibition 1.52 (1.10, 2.10) 0.01 0.94 (0.69, 1.28) 0.71
   Thrill and Adventure 1.91 (1.04, 3.53) 0.04 0.90 (0.65, 1.25) 0.53
   Boredom Susceptibility 0.87 (0.51, 1.48) 0.61 0.80 (0.53, 1.22) 0.31
Note. CI = confidence interval.
Odds ratio represents change in odds of d-AMPH choice per 5-point increase in Total SS
and 2-point increase in each of the subscores. 
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Table 4
Dose-specific effects of sensation seeking and d-AMPH choice
Males (n=16)
5mg 10mg 20mg 
SS Scale Odds ratio 95% CI p Odds ratio 95% CI p Odds ratio 95% CI p
Total 1.62 (0.84, 3.10) 0.15 2.20 (1.23, 3.94) 0.01 1.08 (0.60, 1.96) 0.80
   Experience Seeking 1.20 (0.51, 2.81) 0.68 2.39 (1.21, 4.72) 0.01 2.50 (0.83, 7.51) 0.10
   Disinhibition 1.70 (0.99, 2.92) 0.06 1.81 (0.98, 3.32) 0.06 1.14 (0.76, 1.73) 0.52
   Thrill and Adventure 1.86 (0.98, 4.02) 0.11 2.85 (1.19, 6.86) 0.02 1.32 (0.48, 3.65) 0.59
   Boredom Susceptibility 1.07 (0.54, 2.13) 0.85 1.11 (0.60, 2.02) 0.74 0.52 (0.25, 1.11) 0.09
Females (n=21)
5mg 10mg 20mg 
SS Scale Odds ratio 95% CI p Odds ratio 95% CI p Odds ratio 95% CI p
Total 0.90 (0.50, 1.62) 0.74 0.69 (0.43, 1.11) 0.12 0.73 (0.42, 1.28) 0.28
   Experience Seeking 0.63 (0.33, 1.20) 0.16 0.60 (0.33, 1.09) 0.09 0.68 (0.26, 1.81) 0.44
   Disinhibition 1.09 (0.76, 1.57) 0.62 0.80 (0.53, 1.20) 0.28 0.94 (0.61, 1.45) 0.78
   Thrill and Adventure 0.92 (0.53, 1.59) 0.77 0.81 (0.56, 1.16) 0.25 0.97 (0.64, 1.46) 0.87
   Boredom Susceptibility 0.91 (0.50, 1.63) 0.74 0.89 (0.60, 1.32) 0.56 0.62 (0.36, 1.08) 0.09
Note. CI = confidence interval.
Odds ratio represents change in odds of d-AMPH choice per 5-point increase in Total SS and 2-point increase in each of the subscores.  
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Table 5
Effects of sensation seeking and d-AMPH subjective effects
Males (n=16) Females (n=21)
SS Scale ! 95% CI p ! 95% CI p
Drug Effect
   Total 0.51 (-1.18, 2.21) 0.52 -0.27 (-2.16, 1.61) 0.76
   Experience Seeking -0.33 (-2.66, 1.98) 0.76 -1.13 (-3.96, 1.70) 0.41
   Disinhibition 0.52 (-0.90, 1.95) 0.44 0.04 (-1.61, 1.68) 0.96
   Thrill and Adventure 0.54 (-2.04, 3.12) 0.66 -0.27 (-2.16, 1.62) 0.77
   Boredom Susceptibility 0.54 (-1.24, 2.32) 0.52 0.02 (-1.85, 1.90) 0.98
Good Effect
   Total 0.24 (-1.28, 1.76) 0.74 -0.36 (-2.37, 1.64) 0.71
   Experience Seeking -0.72 (-2.71, 1.26) 0.45 -0.60 (-3.64, 2.44) 0.68
   Disinhibition 0.40 (-0.82, 1.61) 0.49 -0.46 (-2.20, 1.28) 0.58
   Thrill and Adventure 0.47 (-1.80, 2.74) 0.66 0.27 (-1.76, 2.29) 0.79
   Boredom Susceptibility 0.23 (-1.37, 1.82) 0.77 -0.30 (-2.33, 1.72) 0.76
Bad Effect
   Total -0.85 (-2.06, 0.36) 0.15 0.14 (-0.47, 0.75) 0.63
   Experience Seeking -1.87 (-3.24, -0.50) 0.01 0.12 (-0.81, 1.06) 0.79
   Disinhibition -0.43 (-1.51, 0.65) 0.41 0.04 (-0.49, 0.57) 0.88
   Thrill and Adventure -0.71 (-2.59, 1.18) 0.43 -0.15 (-0.76, 0.46) 0.61
   Boredom Susceptibility -0.19 (-1.56, 1.18) 0.77 0.39 (-0.18, 0.97) 0.16
Like Drug
   Total 1.17 (0.19, 2.15) 0.02 0.16 (-2.48, 2.81) 0.90
   Experience Seeking 0.87 (-0.61, 2.36) 0.23 -0.99 (-5.02, 3.03) 0.61
   Disinhibition 1.00 (0.24, 1.75) 0.01 0.50 (-1.76, 2.75) 0.65
   Thrill and Adventure 1.39 (-0.19, 2.98) 0.08 0.23 (-2.44, 2.90) 0.86
   Boredom Susceptibility 0.24 (-1.03, 1.51) 0.69 -0.08 (-2.78, 2.62) 0.95
Stimulant Effect
   Total -0.43 (-2.32, 1.47) 0.63 0.22 (-1.90, 2.34) 0.83
   Experience Seeking -1.31 (-3.74, 1.11) 0.26 -0.81 (-4.03, 2.41) 0.60
   Disinhibition -0.13 (-1.68, 1.43) 0.86 0.25 (-1.59, 2.10) 0.78
   Thrill and Adventure -0.35 (-3.21, 2.50) 0.79 0.31 (-1.85, 2.48) 0.76
   Boredom Susceptibility 0.02 (-2.00, 2.03) 0.99 0.26 (-1.85, 2.37) 0.80
Note. CI = confidence interval.
! represents estimated change in area under the curve per 5-point increase in Total SS and 2-point increase
 in each of the subscores. 
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Table 6
Dose-specific relationships between sensation seeking score and d-AMPH subjective effects in males
Males (n=16)
5mg 10mg 20mg 
SS Scale ! 95% CI p ! 95% CI p ! 95% CI p
Drug Effect
   Total 1.11 (-0.46,2.68) 0.15 0.15 (-1.74, 2.04) 0.87 0.29 (-2.45, 3.02) 0.82
   Experience Seeking 0.77 (-1.48, 3.03) 0.47 -0.22 (-2.77, 2.33) 0.86 -1.58 (-5.16, 2.00) 0.36
   Disinhibition 1.11 (-0.16, 2.39) 0.08 0.15 (-1.45, 1.74) 0.85 0.32 (-1.98, 2.63) 0.77
   Thrill and Adventure 1.43 (-0.99, 3.85) 0.22 -0.62 (-3.44, 2.20) 0.64 0.81 (-3.29, 4.91) 0.68
   Boredom Suseptibility 0.16 (-1.62, 1.95) 0.84 0.62 (-1.33, 2.56) 0.50 0.85 (-1.98, 3.68) 0.53
Good Effect
   Total 0.83 (-0.99, 2.64) 0.34 0.35 (-0.95, 1.66) 0.57 -0.46 (-3.06, 2.15) 0.71
   Experience Seeking -0.06 (-2.58, 2.45) 0.96 0.13 (-1.64, 1.89) 0.88 -2.24 (-5.46, 0.99) 0.16
   Disinhibition 0.93 (-0.49, 2.36) 0.18 0.37 (-0.68, 1.42) 0.46 -0.12 (-2.25, 2.01) 0.91
   Thrill and Adventure 1.31 (-1.40, 4.03) 0.32 0.09 (-1.89, 2.07) 0.92 -0.005 (-3.93, 3.92) 1.00
   Boredom Suseptibility 0.12 (-1.86, 2.10) 0.90 0.23 (-1.15, 1.61) 0.72 0.33 (-2.42, 3.07) 0.80
Bad Effect
   Total -0.13 (-0.80, 0.54) 0.69 -1.19 (-2.66, 0.27) 0.10 -1.22 (-3.50, 1.06) 0.27
   Experience Seeking -0.45 (-1.31, 0.42) 0.29 -2.25 (-3.99, -0.52) 0.01 -2.91 (-5.63, -0.18) 0.04
   Disinhibition 0.10 (-0.47, 0.67) 0.72 -0.62 (-1.95, 0.72) 0.34 -0.77 (-2.75, 1.21) 0.42
   Thrill and Adventure -0.37 (-1.33, 0.60) 0.43 -1.39 (-3.64, 0.86) 0.20 -0.37 (-3.89, 3.15) 0.82
   Boredom Suseptibility -0.05 (-0.75, 0.66) 0.89 -0.28 (-1.98, 1.42) 0.72 -0.25 (-2.75, 2.26) 0.83
Like Drug
   Total 1.35 (-0.14, 2.84) 0.07 0.98 (-0.59, 2.56) 0.20 1.18 (-0.63, 2.99) 0.18
   Experience Seeking 0.63 (-1.56, 2.81) 0.54 1.45 (-0.57, 3.46) 0.14 0.55 (-1.97, 3.06) 0.65
   Disinhibition 1.19 (0.05, 2.24) 0.04 0.80 (-0.45, 2.05) 0.19 0.99 (-0.43, 2.42) 0.16
   Thrill and Adventure 2.10 (-0.08, 4.29) 0.06 0.82 (-1.62, 3.27) 0.48 1.25 (-1.54, 4.03) 0.35
   Boredom Suseptibility 0.19 (-1.60, 1.99) 0.82 -0.03 (-1.81, 1.75) 0.97 0.55 (-1.48, 2.58) 0.57
Stimulant Effect
   Total 0.83 (-0.66, 2.34) 0.25 -1.04 (-3.23, 1.16) 0.33 -1.09 (-4.11, 1.94) 0.45
   Experience Seeking 0.95 (-1.08, 2.97) 0.33 -1.62 (-4.51, 1.26) 0.25 -3.27 (-6.90, 0.37) 0.07
   Disinhibition 0.72 (-0.49, 1.93) 0.22 -0.47 (-2.30, 1.37) 0.59 -0.63 (-3.12, 1.86) 0.59
   Thrill and Adventure 0.90 (-1.39, 3.20) 0.41 -1.64 (-4.90, 1.63) 0.30 -0.32 (-4.95, 4.30) 0.88
   Boredom Suseptibility 0.08 (-1.58, 1.75) 0.92 -0.27 (-2.67, 2.12) 0.81 0.24 (-3.02, 3.49) 0.88
Note. CI = confidence interval.
! represents estimated change in area under the curve per 5-point increase in Total SS and 2-point increase in each of the subscores. 
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Table 7
Dose-specific relationships between sensation seeking score and d-AMPH subjective effects in females
Females (n=21)
5mg 10mg 20mg 
SS Scale ! 95% CI p ! 95% CI p ! 95% CI p
Drug Effect
   Total -0.21 (-1.32, 0.90) 0.70 -0.63 (-3.15, 1.88) 0.60 0.02 (-2.66, 2.69) 0.99
   Experience Seeking -0.90 (-2.53, 0.73) 0.26 -1.30 (-5.11, 2.50) 0.48 -1.17 (-5.20, 2.86) 0.55
   Disinhibition 0.03 (-0.94, 0.99) 0.96 -0.11 (-2.32, 2.09) 0.92 0.19 (-2.13, 2.52) 0.86
   Thrill and Adventure -0.12 (-1.23, 1.00) 0.83 -0.25 (-2.79, 2.28) 0.83 -0.44 (-3.11, 2.23) 0.73
   Boredom Suseptibility -0.04 (-1.14, 1.06) 0.94 -0.60 (-3.09, 1.88) 0.62 0.71 (-1.90, 3.34) 0.57
Good Effect
   Total 0.01 (-1.84, 1.86) 0.99 -0.94 (-3.47, 1.58) 0.44 -0.16 (-2.77, 2.46) 0.90
   Experience Seeking 0.26 (-2.54, 3.07) 0.84 -1.51 (-5.33, 2.32) 0.42 -0.57 (-4.52, 3.39) 0.77
   Disinhibition -0.54 (-2.14, 1.05) 0.48 -0.39 (-2.63, 1.84) 0.71 -0.45 (-2.72, 1.82) 0.68
   Thrill and Adventure 0.64 (-1.20, 2.48) 0.48 0.07 (-2.52, 2.66) 0.96 0.09 (-2.54, 2.73) 0.94
   Boredom Suseptibility -0.002 (-1.87, 1.86) 1.00 -1.27 (-3.78, 1.24) 0.30 0.36 (-2.27, 2.99) 0.78
Bad Effect
   Total 0.001 (-0.64, 0.64) 0.99 -0.10 (-0.86, 0.66) 0.78 0.53 (-0.56, 1.62) 0.32
   Experience Seeking 0.16 (-0.82, 1.14) 0.73 0.24 (-0.91, 1.40) 0.66 -0.04 (-1.76, 1.68) 0.96
   Disinhibition 0.08 (-0.48, 0.64) 0.77 -0.61 (-1.19, -0.02) 0.04 0.64 (-0.28, 1.56) 0.16
   Thrill and Adventure -0.24 (-0.87, 0.39) 0.43 -0.06 (-0.82, 0.69) 0.86 -0.15 (-1.27, 0.97) 0.78
   Boredom Suseptibility 0.07 (-0.57, 0.70) 0.83 0.50 (-0.21, 1.20) 0.15 0.62 (-0.44, 1.68) 0.24
Like Drug
   Total 0.67 (-1.48, 2.82) 0.52 -0.26 (-3.18, 2.65) 0.85 0.07 (-3.45, 3.61) 0.96
   Experience Seeking -0.13 (-3.46, 3.21) 0.94 -1.64 (-6.04, 2.76) 0.44 -1.22 (-6.60, 4.16) 0.64
   Disinhibition 0.26 (-1.60, 2.12) 0.78 0.84 (-1.63, 3.31) 0.48 0.40 (-2.62, 3.42) 0.78
   Thrill and Adventure 0.76 (-1.41, 2.93) 0.47 -0.02 (-2.97, 2.93) 0.99 -0.05 (-3.62, 3.52) 0.98
   Boredom Suseptibility 0.67 (-1.53, 2.86) 0.53 -1.13 (-4.06, 1.80) 0.43 0.22 (-3.37, 3.82) 0.90
Stimulant Effect
   Total 0.24 (-1.25, 1.72) 0.74 -0.13 (-3.14, 2.89) 0.93 0.55 (-2.10, 3.21) 0.67
   Experience Seeking -0.56 (-2.83, 1.70) 0.61 -1.52 (-6.06, 3.02) 0.49 -0.34 (-4.41, 3.73) 0.86
   Disinhibition 0.11 (-1.19, 1.41) 0.86 0.41 (-2.21, 3.03) 0.75 0.25 (-2.08, 2.57) 0.83
   Thrill and Adventure 0.42 (-1.08, 1.93) 0.56 0.51 (-2.55, 3.58) 0.73 0.007 (-2.71, 2.73) 1.00
   Boredom Suseptibility 0.28 (-1.20, 1.76) 0.70 -0.68 (-3.66, 2.30) 0.64 1.19 (-1.40, 3.78) 0.35
Note. CI = confidence interval.
! represents estimated change in area under the curve per 5-point increase in Total SS and 2-point increase in each of the subscores. 
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Figure 1. Estimated probability of d-AMPH choice in males as a function of SS score. 
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Figure 2. Estimated AUC d-AMPH Liking in males as a function of SS score. 
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